BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

30 related articles for article (PubMed ID: 2191585)

  • 1. Spironolactone and altizide in systemic hypertension: ambulatory multicenter study.
    Sternon J
    Am J Cardiol; 1990 Jun; 65(23):24K-27K. PubMed ID: 1972313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aldactazine/captopril combination, safe and effective in mild to moderate systemic hypertension: report on a multicenter study of 967 patients.
    Schohn DC; Spiesser R; Wehrlen M; Pelletier B; Capron MH
    Am J Cardiol; 1990 Jun; 65(23):4K-6K. PubMed ID: 2191589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spironolactone and altizide versus converting enzyme inhibitor (enalapril).
    Grünfeld JP; Wehrlen M; Pelletier B; Capron MH
    Am J Cardiol; 1990 Jun; 65(23):28K-32K. PubMed ID: 2191586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spironolactone and altizide used in combination with enalapril: twenty-four-hour ambulatory recording of blood pressure.
    Poncelet P; Wehrlen M; Pelletier B; Capron MH
    Am J Cardiol; 1990 Jun; 65(23):33K-35K. PubMed ID: 2191587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of spironolactone-altizide on left ventricular hypertrophy.
    Degre S; Detry JM; Unger P; Cosyns J; Brohet C; Kormoss N
    Acta Cardiol; 1998; 53(5):261-7. PubMed ID: 9922803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical update: spironolactone and altizide as monotherapy in systemic hypertension.
    Dueymes JM
    Am J Cardiol; 1990 Jun; 65(23):20K-23K. PubMed ID: 2191585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cardiac risks of hypokalemia and hypomagnesemia].
    Krämer BK; Endemann D
    Ther Umsch; 2000 Jun; 57(6):398-9. PubMed ID: 10894026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The value of diuretics in monotherapy of hypertension].
    Klaus D
    Fortschr Med; 1993 Jun; 111(17):304-8. PubMed ID: 8349274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. K(+) depletion and the progression of hypertensive disease or heart failure. The pathogenic role of diuretic-induced aldosterone secretion.
    Laragh JH; Sealey JE
    Hypertension; 2001 Feb; 37(2 Pt 2):806-10. PubMed ID: 11230377
    [No Abstract]   [Full Text] [Related]  

  • 10. Blood pressure lowering efficacy of diuretics as second-line therapy for primary hypertension.
    Chen JM; Heran BS; Wright JM
    Cochrane Database Syst Rev; 2009 Oct; (4):CD007187. PubMed ID: 19821398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Torasemide in comparison with thiazides in the treatment of hypertension.
    Baumgart P
    Cardiovasc Drugs Ther; 1993 Jan; 7 Suppl 1():63-8. PubMed ID: 8435378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Value of diuretics and aldosterone antagonists in the treatment of heart failure].
    Schwinger RH
    Dtsch Med Wochenschr; 1999 Sep; 124 Suppl 2():S40-7. PubMed ID: 10535046
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.